×
模态框（Modal）标题
在这里添加一些文本
Close
Close
Submit
Cancel
Confirm
×
模态框（Modal）标题
×
导航切换
Journal of International Oncology
Home
About Journal
About Journal
Journal History
Objective
Editorial Committee
Editorial Boards
Communications Editorial Board
Introduction to Editor-in-Chief
General Principles of the Editorial Board
Guide for Authors
Online Submission Guide
Instructions for Authors
Publication Ethics
Aim and Scope
Subscribe
Contacts Us
中文
Comparison of efficacy and safety between sintilimab and tislelizumab in neoadjuvant therapy for advanced esophageal squamous cell carcinoma
Yang Hao, Shi Guidong, Zhang Chengcheng, Zhang Yue, Zhang Liwen, Fu Maoyong
Journal of International Oncology . 2024, (
4
): 210 -216 . DOI: 10.3760/cma.j.cn371439-20230811-00035
